Safety and Efficacy of LCI699 in Cushing's Disease Patients
Clinical trial NCT01331239 · COMPLETED
Trial details
- NCT number
- NCT01331239
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-23
- Primary completion
- 2019-10-22
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.